In Other News

• Blood-Based MRD Test Predicts Recurrence Risk After Melanoma Surgery

• Lollipop-Inspired Device Measures Acetaminophen Levels in Saliva

• Blood Test Detects Molecular Signals of Early Liver Cancer Progression

• New Insights Into Fetal DNA Could Improve Non-Invasive Prenatal Testing

• New Web-Based Platform Helps Autoimmune Laboratories Manage Testing Complexity

• Blood-Based MRD Test Shows High Specificity in Colorectal Cancer Trials

• Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

• New Web-Based Platform Helps Autoimmune Laboratories Manage Testing Complexity

• Population-Scale Proteomics Study Identifies New Genetic-Protein Links

• Genomic Workflow Identifies Fungal Pathogens Before Blood Cultures Turn Positive

• UK Project Advances Blood-Based Dementia Testing Toward Routine Clinical Care

• Noninvasive AI-Enabled Raman Probe Distinguishes Skin Cancers from Normal Tissue

• Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

• Expanded Partnership Supports AI Biomarker Validation and Clinical Trial Deployment

• World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

• Routine Newborn Blood Spots Can Measure GBS Antibody Levels

• Rapid Mass Spectrometry Test May Aid Glioma Margin Decisions

• Facilitated Cascade Program Increases Genetic Testing in Hereditary Cancer Families

• Magnetically Guided Capsule Enables Targeted Small Intestine Microbiome Sampling

• Urine-Based RNA Improves Bladder Cancer Detection and Monitoring

• Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy

• Blood RNA Panel Predicts Lung Cancer Risk Years Before Diagnosis

• Bile DNA Testing Detects Tumor Signals Before Conventional Cancer Diagnosis